Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 1/20 | 0.40 |
| ▸ | SELL | P14151 | 1/20 | 0.40 |
| ▸ | SELP | P16109 | 1/20 | 0.40 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.40 |
| ▸ | MMP12 | P39900 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29373601 | 0.79 | ALDH1A1 (0.57) | PIM1SELLSELPADAMTS4ALDH1A1 | |
| SCHEMBL338346 | 0.79 | ALDH1A1 (0.57) | PIM1SELLSELPADAMTS4ALDH1A1 | |
| SCHEMBL3424179 | 0.79 | ALDH1A1 (0.38) | PIM1SELLSELPADAMTS4ALDH1A1 | |
| Formaldehyde SCHEMBL12802314 | 0.76 | SELL (0.52) | PIM1SELLSELPADAMTS4ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28771575 | 0.75 | ALDH1A1 (0.53) | PIM1SELLSELPADAMTS4ALDH1A1 | |
| Hydrochloric Acid SCHEMBL21799214 | 0.75 | ALDH1A1 (0.53) | PIM1SELLSELPADAMTS4ALDH1A1 | |
| SCHEMBL9144257 | 0.75 | ADRA2A (0.42) | PIM1SELLSELPADAMTS4ALDH1A1 | |
| SCHEMBL22657869 | 0.75 | PTPN1 (0.36) | PIM1SELLSELPADAMTS4ALDH1A1 | |
| SCHEMBL547602 | 0.73 | — | — | |
| SCHEMBL25170487 | 0.69 | TDP1 (0.39) | ALDH1A1CA1CA2LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117295704-A | Fullerene phosphate polydigalloyl and method | 西纳普有限责任公司 | 2023-12-26 | — | — | CN | claimed |
| WO-2011085454-A1 | GP120 -BINDING BENZENE COMPOUNDS AND SACCHARIDE COMPOUNDS | KATHOLIEKE UNIVERSITEIT LEUVEN K.U.LEUVEN R&D (BE) | 2011-07-21 | — | — | WO | claimed |
| EP-1503778-B1 | FORMULATION OF A MIXTURE OF FREE-B-RING FLAVONOIDS AND FLAVANS AS A THERAPEUTIC AGENT | UNIGEN PHARMACEUTICALS INC (US) | 2009-08-05 | — | — | EP | claimed |
| EP-1395251-A2 | AMINEDIOLS AS AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Elan Pharmaceuticals, Inc. (US) | 2004-03-10 | — | — | EP | claimed |
| WO-2002100818-A2 | AMINEDIOLS AS AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2002-12-19 | — | — | WO | claimed |
| US-11759435-B2 | Dihydrochalcone derivatives influencing inflammatory states | SYMRISE AG (DE) | 2023-09-19 | — | — | US | disclosed |
| US-11684912-B2 | Weak ion exchange particulate medium prepared from phenol-containing organic matter for anions contained in aqueous solutions | AMERICAN PEAT TECHNOLOGY, LLC (US) | 2023-06-27 | — | — | US | disclosed |
| US-20230148332-A1 | VACCINE ADJUVANTS | VIROVAX LLC | 2023-05-11 | — | — | US | disclosed |
| EP-4146204-A1 | VACCINE ADJUVANTS | Virovax LLC (US) | 2023-03-15 | — | — | EP | disclosed |
| US-20230024972-A1 | BAKUCHINOYL RETINOATE AND METHODS OF USE THEREOF | PHYTO TECH CORP D/B/A/ BLUE CALIFORNIA CO (US) | 2023-01-26 | — | — | US | disclosed |
| WO-2022266493-A1 | BAKUCHINOYL RETINOATE AND METHODS OF USE THEREOF | PHYTO TECH CORP D/B/A/ BLUE CALIFORNIA CO (US) | 2022-12-22 | — | — | WO | disclosed |
| US-11478411-B2 | Use of chelating agents for improving color stability of resorcinol | CONOPCO, INC. (US) | 2022-10-25 | — | — | US | disclosed |
| US-6153208-A | A WATER INSOLUBLE SUBSTRATE HAVING A SEPARATE CLEANSING AND CONDITIONING PORTIONS WITH DIFFERENT WET EXTENSIBLE, A LATHERING SURFACTANT; DRY WASHCLOTH | THE PROCTER & GAMBLE COMPANY (US) | 2000-11-28 | — | — | US | disclosed |
| EP-1011630-A1 | CLEANSING AND CONDITIONING ARTICLE FOR SKIN OR HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2000-06-28 | — | — | EP | disclosed |
| WO-1999055303-A1 | CLEANSING ARTICLES FOR SKIN AND/OR HAIR WHICH ALSO DEPOSITS SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 1999-11-04 | — | — | WO | disclosed |
| WO-1999013861-A1 | CLEANSING AND CONDITIONING ARTICLE FOR SKIN OR HAIR | THE PROCTER & GAMBLE COMPANY (US) | 1999-03-25 | — | — | WO | disclosed |
| US-5149884-A | Oxidative dehydrogenation of aromatic or aliphatic alcohols in gas phase | BASF AKTIENGESELLSCHAFT (DE) | 1992-09-22 | — | — | US | disclosed |
| US-4600740-A | Hindered dydroxybenzyl hexaalkyldiphenyl-methanes and stabilized compositions | ICI AMERICAS INC. (US) | 1986-07-15 | — | — | US | disclosed |
| US-4224254-A | OXIDATION OF AROMATIC ALCOHOLS, SILVER CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 1980-09-23 | — | — | US | disclosed |
| US-4200706-A | Curing of phenol-formaldehyde resins | CONOCO, INC. (US) | 1980-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230024972-A1 | BAKUCHINOYL RETINOATE AND METHODS OF USE THEREOF | RBP4, RARA, RARB | PIM1 4859/4885SELL 3971/4885SELP 4657/4885 |
| US-20230148332-A1 | VACCINE ADJUVANTS | TLR7, TLR8, TLR1 | PIM1 4582/4885SELL 2440/4885SELP 3578/4885 |
| US-11759435-B2 | Dihydrochalcone derivatives influencing inflammatory states | IL17A, TNF, IL1B | PIM1 4705/4885SELL 893/4885SELP 2692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.